Filed Under:

New Drug Focuses Attention On HIV Prevention

Play associated audio
Following the FDA approval of Truvada — the once-a-day pill that can drastically lower a person's risk of contracting HIV — Audie Cornish talks with Dr. Wafaa El-Sadr of Columbia University's Mailman School of Public Health. They examine the status of HIV prevention efforts in the U.S. today — what progress has been made and the challenges that still ahead. El-Sadr has worked on HIV/AIDS prevention and treatment since 1981.
NPR

Robert Irwin Brings 'Big' To Texas With Permanent Art Installation

The 87-year-old conceptual artist unveils a large-scale installation of his work in Marfa, Texas, this week. He's spent his career creating site-specific art that often treats light as its subject.
NPR

Scraped, Splattered — But Silent No More. Finally, The Dinner Plate Gets Its Say

Instagram is the Internet's semi-obsessive, borderline-creepy love letter to food. But behind every great meal is a plate doing a pretty-OK job. So a comedian made an Instagram to celebrate plates.
NPR

Hillary Clinton Picks Her VP Nominee: Who Is Tim Kaine?

Hillary Clinton has tapped Virginia SenatorTim Kaine to be her running mate, completing the democratic presidential ticket.
NPR

Making The Cloud Green: Tech Firms Push For Renewable Energy Sources

Few people can demand what kind of electricity they get. But Microsoft and Facebook, which operate huge, power-hungry data centers, are trying to green up the electricity grid with their buying power.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.